We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCA
3151
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
$175K ﹤0.01%
13,101
-4,255
-25% -$59.1K
CRR
3152
DELISTED
Carbo Ceramics Inc.
CRR
$173K ﹤0.01%
+23,850
New +$206K
LNTH icon
3153
Lantheus
LNTH
$6.59B
$172K ﹤0.01%
+10,840
New +$211K
SMRT
3154
DELISTED
Stein Mart Inc
SMRT
$170K ﹤0.01%
111,531
+40,896
+58% +$38.3K
EDD
3155
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$385M
$169K ﹤0.01%
21,554
-3,419
-14% -$27.3K
MAT icon
3156
Mattel
MAT
$4.21B
$169K ﹤0.01%
12,827
-6,108
-32% -$95.2K
NIM icon
3157
Nuveen Select Maturities Municipal Fund
NIM
$116M
$169K ﹤0.01%
17,450
+200
+1% +$1.95K
SPWR
3158
DELISTED
SunPower Corporation Common Stock
SPWR
$169K ﹤0.01%
32,430
-13,493
-29% -$68.7K
FLWS icon
3159
1-800-Flowers.com
FLWS
$255M
$168K ﹤0.01%
14,200
-100
-0.7% -$1.16K
MCI
3160
Barings Corporate Investors
MCI
$341M
$168K ﹤0.01%
11,156
+38
+0.3% +$573
NAGE
3161
Niagen Bioscience
NAGE
$241M
$168K ﹤0.01%
+40,001
New +$209K
UBNK
3162
DELISTED
United Financial Bancorp, Inc.
UBNK
$168K ﹤0.01%
10,374
+300
+3% +$4.97K
DMF
3163
DELISTED
BNY Mellon Municipal Income
DMF
$167K ﹤0.01%
20,648
+3,902
+23% +$32.6K
GLP icon
3164
Global Partners
GLP
$1.7B
$167K ﹤0.01%
10,868
-1,331
-11% -$22.8K
DIS icon
3165
CALL
Walt Disney
DIS
$178B
$165K ﹤0.01%
42,900
+32,600
+317% +$3.46M
SSRM icon
3166
SSR Mining
SSRM
$6.4B
$165K ﹤0.01%
17,236
-2,100
-11% -$18.4K
CELP
3167
DELISTED
Cypress Environmental Partners, L.P.
CELP
$165K ﹤0.01%
29,542
-2,858
-9% -$18.6K
FSM icon
3168
Fortuna Silver Mines
FSM
$3.18B
$164K ﹤0.01%
31,532
-5,781
-15% -$27.8K
MYN icon
3169
BlackRock MuniYield New York Quality Fund
MYN
$376M
$164K ﹤0.01%
13,604
NCA icon
3170
Nuveen California Municipal Value Fund
NCA
$303M
$164K ﹤0.01%
17,584
-4,000
-19% -$38.8K
PFE icon
3171
CALL
Pfizer
PFE
$154B
$164K ﹤0.01%
267,505
-100,763
-27% -$3.46M
BSX icon
3172
CALL
Boston Scientific
BSX
$73.1B
$162K ﹤0.01%
17,100
-2,800
-14% -$76.1K
CDZI icon
3173
Cadiz
CDZI
$279M
$162K ﹤0.01%
12,000
EHI
3174
Western Asset Global High Income Fund
EHI
$178M
$162K ﹤0.01%
17,250
-472
-3% -$4.63K
FUND
3175
Sprott Focus Trust
FUND
$312M
$162K ﹤0.01%
20,848

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.